Accelerating Science: How to cure the incurable with cell and gene therapy

ioMicroglia Human iPSC-derived microglia by bit.bio

Manufacturer bit.bio  |   Model: io1021  |  Available Worldwide
ioMicroglia are human induced pluripotent stem cell (iPSC)-derived microglia, precision reprogrammed using opti-ox™ technology. Within 10 days post-revival, ioMicroglia are ready for experimentation, expressing (>90%) key markers, including TMEM119, P2RY12, and IBA1. ioMicroglia display key functional traits including phagocytosis and proinflammatory cytokine secretion and can be co-cultured with ioGlutamatergic Neurons™.


ioMicroglia Human iPSC-derived microglia by bit.bio product image
ioMicroglia are delivered cryopreserved
Request Pricing

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

bit.bio’s opti-ox powered precision cellular reprogramming converts human pluripotent stem cells into highly defined and functional microglia within days. ioMicroglia provide a consisntet, rapid, functional, and co-culture compatible hiPSC-based model for neurodegenerative disease research and drug development.

Key features:

  • Quick: rapidly maturing human microglia that are ready to use within 10 days post-revival.
  • Functional: ioMicroglia display key phagocytic and cytokine secretion functions.
  • Co-culture compatible: suitable for co-culture studies with neurons. 

Applications:

neurodegenerative disease modeling and drug development, neuroinflammation research, co-culture studies, and transcriptome analysis.

Product Overview

ioMicroglia Human iPSC-derived microglia by bit.bio product image

ioMicroglia Human iPSC-derived microglia

Manufacturer bit.bio  |  Available Worldwide

Be the first to review this product